This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: The University of Texas System. Active years: 2022-2023.
Company Filing History:
Years Active: 2022-2023
Title: Innovations by Wei-Chung Chiang
Introduction
Wei-Chung Chiang is a notable inventor based in Dallas, TX (US). He has made significant contributions to the field of autophagy research, holding 2 patents that focus on small molecule inducers and disruptors of protein-protein interactions.
Latest Patents
Chiang's latest patents include innovative small molecules that disrupt Beclin-1/Bcl-2 protein-protein interactions. These molecules induce autophagy, which is therapeutically useful for treating various conditions, including cancer, infection immunity, neurodegeneration, and longevity. His work in this area has the potential to impact multiple therapeutic applications.
Career Highlights
Wei-Chung Chiang is affiliated with the University of Texas System, where he continues to advance his research. His work has garnered attention for its implications in health and disease management.
Collaborations
Chiang collaborates with esteemed colleagues such as Qiren Liang and Jef De Brabander, contributing to a dynamic research environment that fosters innovation.
Conclusion
Wei-Chung Chiang's contributions to the field of autophagy through his patents and collaborations highlight his role as a significant inventor in modern science. His work promises to pave the way for new therapeutic strategies in treating various diseases.